| Mobile Foot Doctors, P.a. | |
|
825 Quewhiffle Rd, Aberdeen, NC 28315-5371 | |
| (910) 684-0522 | |
| Not Available |
| Full Name | Mobile Foot Doctors, P.a. |
|---|---|
| Type | Facility |
| Speciality | Podiatrist |
| Location | 825 Quewhiffle Rd, Aberdeen, North Carolina |
| Accepts Medicare Assignments | Does not participate in Medicare Program. The facility may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1316191604 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213E00000X | Podiatrist | 531 (North Carolina) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mobile Foot Doctors, P.a. 825 Quewhiffle Rd, Aberdeen, NC 28315-5371 Ph: (910) 684-0522 | Mobile Foot Doctors, P.a. 825 Quewhiffle Rd, Aberdeen, NC 28315-5371 Ph: (910) 684-0522 |
News Archive
Depression is common in people with multiple sclerosis (MS), and a new study shows that people with both conditions may be more likely to die over the next decade than people with just one or neither condition.
Acceleron Pharma, Inc., a biopharmaceutical company developing novel protein therapeutics that regulate the growth and development of tissues and cells, including muscle, bone, red blood cells, and vasculature, today announced the presentation of interim results from the first-in-human clinical study of ACE-041 in patients with advanced cancer at the 22nd EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics in Berlin, Germany.
In other health IT news, a study found that Google-type word searches of hospital medical records are better at detecting patient safety issues than searches using numerical billing codes.
New research presented today at the World Congress Summit to Improve Adherence and Enhance Patient Engagement by researchers from the University of Pittsburgh School of Pharmacy, finds that a unique generic medication sampling program, the MedVantx MedStart™ Connect program, implemented in the primary care physicians' office, led to significantly increased patient initiation of new prescriptions (primary adherence) as well as continued use of the medications (secondary adherence), and could possibly lead to savings for health plans.
The U.S. will provide an additional $7.5 million in humanitarian assistance for refugees and internally displaced persons in Cote d'Ivoire and Liberia, according to a statement from the State Department on Wednesday, RTTNews reports.
› Verified 7 days ago